Necessity and concerns beliefs and HIV medication adherence: a systematic review

被引:0
作者
Luke D. Mitzel
Peter A. Vanable
机构
[1] Syracuse University,Department of Psychology
来源
Journal of Behavioral Medicine | 2020年 / 43卷
关键词
Medication adherence; Necessity; Concerns; Medication beliefs; HIV;
D O I
暂无
中图分类号
学科分类号
摘要
According to the Necessity-Concerns Framework, beliefs about medication necessity and concerns are two core themes from diverse patient medication beliefs across chronic illnesses that may directly influence adherence. Past work has supported associations of necessity and concerns to adherence in the chronic disease literature and in HIV research. However, there has not been a focused review of the literature on associations of necessity and concerns to HIV medication adherence, nor on what variables may influence these associations. This systematic review synthesized findings from 26 studies regarding associations of necessity and concerns to HIV medication adherence. Both beliefs showed small, clinically significant effects on adherence. A subset of studies identified perceptions of healthcare providers as determinants of necessity and concerns beliefs with indirect effects on adherence. Overall, necessity and concerns demonstrated clinically significant associations to adherence among people with HIV.
引用
收藏
页码:1 / 15
页数:14
相关论文
共 259 条
[1]  
Batchelder AW(2014)Differential medication nonadherence and illness beliefs in co-morbid HIV and type 2 diabetes Journal of Behavioral Medicine 37 266-275
[2]  
Gonzalez JS(2016)Antiretroviral adherence and treatment outcomes among adult Ethiopian patients AIDS Care 28 1018-1022
[3]  
Berg KM(2016)Adherence to antiretroviral therapy and virologic failure: A meta-analysis Medicine (Baltimore) 95 e3361-1158
[4]  
Bezabhe WM(2018)Determinants of suboptimal adherence and elevated HIV viral load in pregnant women already on antiretroviral therapy when entering antenatal care in cape town, south africa AIDS Care 25 1149-S155
[5]  
Chalmers L(2013)Social-cognitive correlates of antiretroviral therapy adherence among HIV-infected individuals receiving infectious disease care in a medium-sized northeastern US city AIDS Care 43 S149-505
[6]  
Bereznicki LR(2006)The elusive gold standard. Future perspectives for HIV adherence assessment and intervention Journal of Acquired Immune Deficiency Syndromes 365 493-377
[7]  
Gee P(2011)Prevention of HIV-1 infection with early antiretroviral therapy The New England Journal of Medicine 53 369-713
[8]  
Peterson GM(2010)The impact of once-nightly versus twice-daily dosing and baseline beliefs about HAART on adherence to efavirenz-based HAART over 48 weeks: The NOCTE study Journal of Acquired Immune Deficiency Syndromes 23 705-462
[9]  
Bezabhe WM(2011)Beliefs about antiretroviral therapy, treatment adherence and quality of life in a 48-week randomised study of continuation of zidovudine/lamivudine or switch to tenofovir DF/emtricitabine, each with efavirenz AIDS Care 49 460-156
[10]  
Chalmers L(2008)Lower perceived necessity of HAART predicts lower treatment adherence and worse virological response in the ATHENA cohort Journal of Acquired Immune Deficiency Syndromes 52 146-287